I'm remaining cautiously optimistic, and watching this very closely. From many previous experiences working in medical research there are alot of delays in recruitment, study results, and publication. Although the Duke study finished positively, there were only five verified patients. This will be a tough sell at first and may take some time to catch fire. There's always that one big investor out there... can they catch the interest of this person remains to be seen.
WLSI is really pouring every last resource into this. I'd hate to see a good product with great potential unravel at this stage. It'll catch somebody's eye, let's just hope sooner than later.
News 
Market Data 
Discover 
